Skip to Content

IG 269 (Quinapril hydrochloride 20 mg)

Pill imprint IG 269 has been identified as Quinapril hydrochloride 20 mg.

Quinapril is used in the treatment of left ventricular dysfunction; diabetic kidney disease; high blood pressure; heart failure; alport syndrome and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Quinapril 20 mg is not a controlled substance under the Controlled Substance Act (CSA).

Quinapril hydrochloride 20 mg IG 269
Quinapril hydrochloride 20 mg IG 269 Front
Quinapril hydrochloride 20 mg IG 269 Back
Quinapril hydrochloride 20 mg IG 269
Quinapril hydrochloride 20 mg IG 269
Quinapril hydrochloride
Imprint:
IG 269
Strength:
20 mg
Color:
Brown
Shape:
Round
Availability:
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Dr. Reddy’s Laboratories Inc.
National Drug Code (NDC):
55111-0623
Inactive Ingredients:
lactose monohydrate
magnesium carbonate
magnesium stearate
crospovidone
povidone
hypromellose
titanium dioxide
polyethylene glycol
ferric oxide red
ferric oxide yellow

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide